English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Nufarm unfazed on refinancingqrcode

Oct. 3, 2011

Favorites Print
Forward
Oct. 3, 2011
Nufarm will "comfortably" get its refinancing in place by December, the crop protection group says, and foreshadows an aggressive push into the $1.4 billion azoxystrobin fungicide market as part of its strategy to diversify into a broader range of agricultural chemicals.

In a briefing with analysts yesterday, Nufarm managing director Doug Rathbone said $600 million in fresh facilities would be "comfortably in place in time", The Australian Financial Review reports.

His comments came a day after Nufarm handed down an improved operating performance after opting to sell higher-margin products rather than higher-volume, low-margin sales, particularly for key weedkiller compound glyphosate.

The result, a 68 per cent increase in underlying profit, triggered a mixed reaction from analysts.

Wilson HTM analyst James Ferrier upgraded his price target from $5.20 a share to $5.40 after increasing his fiscal 2012 profit forecast by 9 per cent to $127 million.

Goldman Sachs maintained its "hold" rating and said operating conditions were improving, and Deutsche Bank downgraded its rating to "sell" because the stock was trading at a 15 per cent premium to its $3.75 valuation.
Source: farmonline

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox